MECHANISM OF MONONUCLEAR CELL ACTIVATION BY AN ANTI-CD43 (SIALOPHORIN) AGONISTIC ANTIBODY

被引：0
|
作者：
SILVERMAN, LB
WONG, RCK
REMOLDODONNELL, E
VERCELLI, D
SANCHO, J
TERHORST, C
ROSEN, F
GEHA, R
CHATILA, T
机构：
[1] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,CTR BLOOD RES,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,MOLEC IMMUNOL LAB,BOSTON,MA 02115
[4] HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV ALLERGY & IMMUNOL,BOSTON,MA 02115
[5] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
来源：
JOURNAL OF IMMUNOLOGY | 1989年 / 142卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：4194 / 4200
页数：7
相关论文
共 50 条
  • [31] CD43 AS A CORECEPTOR IN T-CELL ACTIVATION
    ROSENSTEIN, Y
    LEE, K
    IGRAS, V
    BURAKOFF, SJ
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A268 - A268
  • [32] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    T Oyama
    Y Kagami
    M Seto
    Y Morishima
    Leukemia, 2001, 15 : 1667 - 1667
  • [33] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    Oyama, T
    Kagami, Y
    Seto, M
    Morishima, Y
    LEUKEMIA, 2001, 15 (10) : 1667 - 1667
  • [34] Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
    Xianglei Yan
    Sebastian Ols
    Rodrigo Arcoverde Cerveira
    Klara Lenart
    Fredrika Hellgren
    Kewei Ye
    Alberto Cagigi
    Marcus Buggert
    Falk Nimmerjahn
    Jesper Falkesgaard Højen
    Daniel Parera
    Ulrich Pessara
    Stephan Fischer
    Karin Loré
    Cellular and Molecular Life Sciences, 2023, 80
  • [35] Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
    Yan, Xianglei
    Ols, Sebastian
    Arcoverde Cerveira, Rodrigo
    Lenart, Klara
    Hellgren, Fredrika
    Ye, Kewei
    Cagigi, Alberto
    Buggert, Marcus
    Nimmerjahn, Falk
    Hojen, Jesper Falkesgaard
    Parera, Daniel
    Pessara, Ulrich
    Fischer, Stephan
    Lore, Karin
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (07)
  • [36] Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice
    Yalamanoglu, Ayla
    Dubach, Irina L.
    Schulthess, Nadja
    Ingoglia, Giada
    Swindle, Delaney C.
    Humar, Rok
    Schaer, Dominik J.
    Buehler, Paul W.
    Irwin, David C.
    Vallelian, Florence
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [37] Multivalent Porous Silicon Nanoparticles Enhance the Immune Activation Potency of Agonistic CD40 Antibody
    Gu, Luo
    Ruff, Laura E.
    Qin, Zhengtao
    Corr, Maripat
    Hedrick, Stephen M.
    Sailor, Michael J.
    ADVANCED MATERIALS, 2012, 24 (29) : 3981 - 3987
  • [38] Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer
    Gauttier, Vanessa
    Judor, Jean-Paul
    Le Guen, Valentin
    Cany, Jeannette
    Ferry, Nicolas
    Conchon, Sophie
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (12) : 2857 - 2867
  • [39] Alteration of enzymatic properties of cell-surface antigen CD38 by agonistic anti-CD38 antibodies that prolong B cell survival and induce activation
    Hara-Yokoyama, Miki
    Kimura, Tomoko
    Kaku, Hiroaki
    Wakiyama, Motoaki
    Kaitsu, Yoko
    Inoue, Mio
    Kusano, Seisuke
    Shirouzu, Mikako
    Yokoyama, Shigeyuki
    Katada, Toshiaki
    Hirabayashi, Yoshio
    Takatsu, Kiyoshi
    Yanagishita, Masaki
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (01) : 59 - 70
  • [40] Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity
    Ishihara, Jun
    Ishihara, Ako
    Potin, Lambert
    Hosseinchi, Peyman
    Fukunaga, Kazuto
    Damo, Martina
    Gajewski, Thomas F.
    Swartz, Melody A.
    Hubbell, Jeffrey A.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (11) : 2399 - 2411
12345